Molina Healthcare Inc

MOH is in a Stage 3 distribution regime with bearish medium-term structure following a decisive Support Failure. Price has broken below key short-term EMAs with follow-through, indicating rejection and continuation of the downtrend. Relative weakness versus benchmarks and rolling EMAs reinforce bearish conviction. With EMAs now acting as resistance, short-term timing favors selling on rallies. Under a Speculative approach, we favor rapid sell-side engagement rather than waiting for deeper pullbacks.

• ↑Q1 premium revenue $10.2B, EPS $2.35 tops $1.57 est.
• ↑Secured $6B Florida contract enhances incremental revenue pipeline.
• ↓Elevated medical cost trends pressurize MCR at 91.1%, squeezing margins.